Delivery Order SPE2DB22D2007-SPE2DB24FJ0AH
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $4.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,449.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and operates out of its corporate office in Conshohocken, Pennsylvania. This delivery order is part...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the provision of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,578.00, has a completion date of March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, will deliver the pharmaceutical products to support military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,841.00 contract is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order does not have a set-aside designation and is scheduled for completion by March 4, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $1,578.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,365.96, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product, MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a potential value of $1,707.42 and a completion date of February 29, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,027.24 to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $3,945.00 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization based in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract, valued at $6,561.35, is for the supply of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML to support military treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor and is responsible for...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0AHDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract, valued at $4,208.00, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to Conshohocken, Pennsylvania by March 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide. This contract award does not have a set-aside designation.
Generated 5/30/24, 10:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 2/29/24 |